Company Filing History:
1 out of 1 
1 out of 497 Years Active: 2025
Title: Jiahui Luo: Innovator in Biotechnology
Introduction
Jiahui Luo is a prominent inventor based in Wuhan, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative antibodies and antigens. With a total of 2 patents, his work has the potential to impact various medical applications.
Latest Patents
Luo's latest patents include a phosphorylated antigen and antibody at the SER23 site of the PGAM1 protein, along with preparation methods and applications. This application focuses on a phosphorylated antigen at the Ser23 site of the PGAM1 protein and a method for preparing an antibody directed to this antigen. The amino acid sequence of the phosphorylated polypeptide is detailed in SEQ ID NO.3, where the phosphorylation site is serine. Another notable patent is the anti-receptor expressed on lymphoid tissues (RELT) recombinant monoclonal antibody, which includes a heavy chain variable region and a light chain variable region. The amino acid sequences for these regions are provided in SEQ ID NO: 4 and SEQ ID NO: 5, respectively. This antibody has the biological activity of neutralizing the function of RELT, allowing for specific recognition and detection of RELT expression in various tissues and cells.
Career Highlights
Throughout his career, Jiahui Luo has worked with esteemed institutions such as Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology. His research has been pivotal in advancing the understanding of immunology and biotechnology.
Collaborations
Luo has collaborated with notable colleagues, including Congyi Wang and Shanjie Rong, who have contributed to his research endeavors.
Conclusion
Jiahui Luo's innovative work in biotechnology, particularly in the development of antibodies and antigens, showcases his commitment to advancing medical science. His contributions are expected to have a lasting impact on the field.